Your browser doesn't support javascript.
loading
Conditional survival and long-term efficacy with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma.
Motzer, Robert J; McDermott, David F; Escudier, Bernard; Burotto, Mauricio; Choueiri, Toni K; Hammers, Hans J; Barthélémy, Philippe; Plimack, Elizabeth R; Porta, Camillo; George, Saby; Powles, Thomas; Donskov, Frede; Gurney, Howard; Kollmannsberger, Christian K; Grimm, Marc-Oliver; Barrios, Carlos; Tomita, Yoshihiko; Castellano, Daniel; Grünwald, Viktor; Rini, Brian I; McHenry, M Brent; Lee, Chung-Wei; McCarthy, Jennifer; Ejzykowicz, Flavia; Tannir, Nizar M.
Affiliation
  • Motzer RJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • McDermott DF; Division of Medical Oncology, Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center, Boston, Massachusetts.
  • Escudier B; Department of Medical Oncology, Gustave Roussy, Villejuif, France.
  • Burotto M; Bradford Hill Clinical Research Center, Santiago, Chile.
  • Choueiri TK; Department of Medical Oncology, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts.
  • Hammers HJ; Department of Medical Oncology, University of Texas Southwestern Kidney Cancer Program, Dallas, Texas.
  • Barthélémy P; Medical Oncology, Strasbourg European Cancer Institute, Strasbourg, France.
  • Plimack ER; Department of Hematology and Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Porta C; Department of Internal Medicine, University of Pavia, Pavia, Italy.
  • George S; Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York.
  • Powles T; Department of Genitourinary Oncology, Barts Cancer Institute, Cancer Research UK Experimental Cancer Medicine Center, Queen Mary University of London, Royal Free National Health Service Trust, London, United Kingdom.
  • Donskov F; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
  • Gurney H; Department of Medical Oncology, Westmead Hospital and Macquarie University, Sydney, New South Wales, Australia.
  • Kollmannsberger CK; Department of Medicine, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
  • Grimm MO; Department of Urology, Jena University Hospital, Jena, Germany.
  • Barrios C; Oncology Research Unit, Saint Luke Hospital, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil.
  • Tomita Y; Departments of Urology and Molecular Oncology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Castellano D; Medical Oncology Department, October 12th University Hospital, Cancer Network Biomedical Research Center, Madrid, Spain.
  • Grünwald V; Interdisciplinary Genitourinary Oncology, West German Cancer Center Clinic for Internal Medicine and Clinic for Urology, University Hospital Essen, Essen, Germany.
  • Rini BI; Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • McHenry MB; Department of Biostatistics, Bristol Myers Squibb, Princeton, New Jersey.
  • Lee CW; Department of Clinical Trials, Bristol Myers Squibb, Princeton, New Jersey.
  • McCarthy J; Department of Clinical Scientists, Bristol Myers Squibb, Princeton, New Jersey.
  • Ejzykowicz F; Department of Health Economics and Outcomes Research, Bristol Myers Squibb, Princeton, New Jersey.
  • Tannir NM; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cancer ; 128(11): 2085-2097, 2022 06 01.
Article de En | MEDLINE | ID: mdl-35383908
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Néphrocarcinome / Tumeurs du rein Type d'étude: Clinical_trials Limites: Female / Humans / Male Langue: En Journal: Cancer Année: 2022 Type de document: Article
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Néphrocarcinome / Tumeurs du rein Type d'étude: Clinical_trials Limites: Female / Humans / Male Langue: En Journal: Cancer Année: 2022 Type de document: Article